SCAI 2026 Workshop on the Treatment of Pulmonary Embolism-Panel Discussion 2

Video Transcription

Video Summary

The panel discussed whether new guidelines have changed practice. Andrew said they support sending some PE patients home with DOACs and scheduled follow-up, empowering ER physicians. Kenny said HiPytho gives strong evidence that treatment lowers clinical deterioration in intermediate-high-risk PE, with a low number needed to treat. The group then discussed future guideline updates: focused updates may follow once more trial data arrive, likely after ongoing studies like HiPytho, PE-TRACT, and PEERLESS-2. They noted current guidelines address more than advanced therapies, so releasing them now helps guide overall PE care while awaiting future evidence.

Asset Caption

closed captions are computer-generated

Keywords

pulmonary embolism

DOACs

guidelines

clinical deterioration

trial data